7 drugs that raised eyebrows in Q3

7 drugs that raised eyebrows in Q3

Promising rare conditions treatments could upend the market hierarchy

Promising rare conditions treatments could upend the market hierarchy

How Biotech is Mastering Multiple Sclerosis: A Review

With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis. Roche may be the first, but others in the biotech community are also working hard to bring their own therapeutics for the disease to market. Multiple sclerosis (MS) is an autoimmune disease that affects the nervous system, and around 2 … Συνεχίστε να διαβάζετε How Biotech is Mastering Multiple Sclerosis: A Review.